HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) All Versions of this Article: jnumed.107.050294v1 49/6/871    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Related articles in JNM Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Google Scholar Articles by Rudd, J. H.F. Articles by Fayad, Z. A. PubMed PubMed Citation Articles by Rudd, J. H.F. Articles by Fayad, Z. A.

Atherosclerosis Inflammation Imaging with ¹⁸F-FDG PET: Carotid, Iliac, and Femoral Uptake Reproducibility, Quantification Methods, and Recommendations

¹ Imaging Science Laboratories, Mount Sinai School of Medicine, New York, New York; ² Cardiovascular Imaging Clinical Trials Unit, Mount Sinai School of Medicine, New York, New York; ³ Division of Nuclear Medicine, Department of Radiology, Mount Sinai School of Medicine, New York, New York; ⁴ Mount Sinai School of Medicine, New York, New York, and Merck Research Laboratories, Rahway, New Jersey; and ⁵ The Zena and Michael A. Wiener Cardiovascular Institute and Marie-Josée and Henry R. Kravis Cardiovascular Health Center, Mount Sinai School of Medicine, New York, New York

Correspondence: For correspondence or reprints contact either of the following: James Rudd, ACCI, Box 110, Addenbrokes Hospital, Cambridge CB2 2QQ, U.K. E-mail: jhfr2{at}cam.ac.uk Zahi A. Fayad, ISL, Mount Sinai School of Medicine, One Gustave L. Levy Place, Box 1030, New York, NY 10029. E-mail: zahi.fayad{at}mssm.edu

Atherosclerosis imaging with ¹⁸F-FDG PET is useful for tracking inflammation within plaque and monitoring the response to drug therapy. Short-term reproducibility of this technique in peripheral artery disease has not been assessed, and the optimal method of ¹⁸F-FDG quantification is still debated. We imaged 20 patients with vascular disease using ¹⁸F-FDG PET twice, 14 d apart, and used these data to assess reproducibility measures and compare 2 methods of ¹⁸F-FDG uptake measurement. We also reviewed the literature on quantification methods to determine the optimal measures of arterial ¹⁸F-FDG uptake for future studies. Methods: Twenty patients with vascular disease underwent PET/CT of the iliac, femoral, and carotid arteries 90 min after ¹⁸F-FDG administration. In 19 patients, repeat testing was performed at 2 wk. Coregistration and attenuation correction were performed with CT. Vessel ¹⁸F-FDG uptake was measured as both the mean and maximum blood-normalized standardized uptake value (SUV), known as the target-to-background ratio (TBR). We assessed interscan, interobserver, and intraobserver agreement. Results: Nineteen patients completed both imaging sessions. The carotid and peripheral arteries all have excellent short-term reproducibility of the ¹⁸F-FDG signal, with intraclass correlation coefficients all greater than 0.8 for all measures of reproducibility. Both mean and maximum TBR measurements for quantifying ¹⁸F-FDG uptake are equally reproducible. ¹⁸F-FDG uptake was significantly higher in the carotid arteries than in both iliac and femoral vessels (P < 0.001 for both). Conclusion: We found that both mean and maximum TBR in the carotid, iliac, and femoral arteries were highly reproducible. We suggest the mean TBR be used for tracking systemic arterial therapies, whereas the maximum TBR is optimal for detecting and monitoring local, plaque-based therapy.

Key Words: atherosclerosis • positron emission tomography • ¹⁸F-FDG • inflammation • methodology

^* Contributed equally to this work.

COPYRIGHT © 2008 by the Society of Nuclear Medicine, Inc.

Related articles in JNM:

This Month in JNM

JNM 2008 49: 13A-14A. [Full Text]